Advancements in antibody-drug conjugates as cancer therapeutics
Antibody-drug conjugates (ADCs) represent a promising approach in targeted cancer therapy, combining the targeted precision of antibodies with the potency of cytotoxic payloads to selectively target tumour cell whilst minimising off-target effects. This review provides a comprehensive analysis of AD...
Saved in:
| Main Authors: | Jung Yin Fong, Zhixin Phuna, Di Yang Chong, Christophorus Manuel Heryanto, Yu Shyan Low, Khang Chiang Oh, Yan Huen Lee, Allan Wee Ren Ng, Lionel Lian Aun In, Michelle Yee Mun Teo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Journal of the National Cancer Center |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005425000432 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01) -
Exploration of the antibody–drug conjugate clinical landscape
by: Heather Maecker, et al.
Published: (2023-12-01) -
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
by: Ruili Wang, et al.
Published: (2025-04-01) -
Antibody-drug conjugates in cancer therapy: applications and future advances
by: Rou Long, et al.
Published: (2025-05-01) -
Linker-GPT: design of Antibody-drug conjugates linkers with molecular generators and reinforcement learning
by: An Su, et al.
Published: (2025-07-01)